Skip to main content

PGD conditions

This table shows all PGD conditions currently approved and awaiting consideration by the HFEA.

Please note that we are updating this database, and some approved conditions may not be displayed. If you are unsure if a condition has been approved or not, please contact pgd@hfea.gov.uk.

Condition name Status OMIM number Documents
Melanoma Pancreatic Cancer Syndrome approved 606719
Melanoma, cutaneous malignant, susceptibility to, 10 (CMM10) approved 615848
Melanoma, cutaneous malignant, susceptibility to, 2 (CMM2) approved 155601
Melanoma, cutaneous malignant, susceptibility to, 3 (CMM3) approved 609048
Melanoma-Astrocytoma Syndrome approved 155755
MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like episodes) approved 540000
Melnick Needles Syndrome approved 309350
Menkes disease approved 309400
Mental Retardation, autosomal recessive 65 approved 618109
Mental Retardation, X-linked, Syndromic 34, caused by NONO gene mutation (MRXS34) approved 300967
Mental Retardation, X-linked, syndromic, Claes-Jensen type (MRXSCJ) approved 300534
Merosin Deficient Congenital Muscular Dystrophy type 1A (MDC1A) (also known as LAMA2-related Muscular Dystrophy) approved 607855
Metabolic Crises, Recurrent, with Rhabdomyolysis, Cardiac Arrhythmias, and Neurodegeneration (MECRCN) approved 616878
Metachromatic Leukodystrophy (MLD) approved 250100
Metaphyseal Dysplasia without Hypotrichosis approved 250460
Methylmalonic Acidemia (MMA) approved 251000
Methylmalonic Acidemia cb1A approved 251100
Methylmalonic Acidemia cb1B approved 251110
Methylmalonic Aciduria and Homocystinuria approved 277400
Micro Syndrome (WARBM) approved 600118